MRK vs VTRS
By Alex · Tickerpine
Merck & Co., Inc. vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | VTRS |
|---|---|---|
| Price | $128.66 | $16.33 |
| Market cap | $317.77B | $19.02B |
| P/E ratio | 36.2 | — |
| ROE | 18.94% | -1.96% |
| Profit margin | 13.59% | -2.04% |
| Revenue growth | 4.90% | 8.10% |
| Dividend yield | 2.64% | 2.94% |
| Beta | 0.22 | 0.90 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs VTRS in plain English
- MRK is the bigger company — about 16.7× the market cap of VTRS.
- MRK earns a higher return on equity (19% vs -2%).
- VTRS is growing revenue faster (8% vs 5%).
- VTRS has the higher dividend yield (2.94% vs 2.64%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.